Clinical Trials Directory

Trials / Completed

CompletedNCT00493597

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

Blood Endothelium Progenitor Cells and Dendritic Cells as Novel Predictive Biomarkers of In-stent Restenosis After Percutaneous Coronary Intervention.

Status
Completed
Phase
Study type
Observational
Enrollment
124 (actual)
Sponsor
University Hospital, Antwerp · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

clinically relevant in stent restenosis occurs in 5-10% of the non-diabetic patients treated with a coronary bare metal stent. Recent research has identified endothelial progenitor cells as well as dendritic cells as components of neointima. Numerical and functional evaluation of endothelial progenitor and dendritic cells at the time of coronary stent implantation is assessed and the relation with clinical and/or angiographic restenosis at 6 months post-stent implantation is evaluated.

Conditions

Timeline

Start date
2007-10-01
Primary completion
2020-10-26
Completion
2020-10-26
First posted
2007-06-28
Last updated
2022-11-04

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00493597. Inclusion in this directory is not an endorsement.

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis (NCT00493597) · Clinical Trials Directory